Call for Abstract

General Information

  • Track 1-1: Vascular Dementia
  • Track 1-2: Digital Dementia
  • Track 1-3: Frontotemporal dementia
  • Track 1-4: TBI, Stroke & Dementia
  • Track 1-5: Other disorders linked to Dementia

  • Track 2-1: Society & Culture

  • Track 3-1: Hallmarks of AD
  • Track 3-2: Stages
  • Track 3-3: Diagnosis
  • Track 3-4: Treatment

  • Track 5-1: Role of Tau protein
  • Track 5-2: Amyloid plaque

  • Track 6-1: Neuropsychological tests
  • Track 6-2: Cognitive tests
  • Track 6-3: Computed tomography
  • Track 6-4: Neuroimaging

  • Track 7-1: Combination Therapy
  • Track 7-2: Pharmacological treatments
  • Track 7-3: Non-pharmacological intervention

  • Track 8-1: Neurotransmitter based
  • Track 8-2: Neuroprotective
  • Track 8-3: Anti-inflammatory
  • Track 8-4: Cognitive enhancers

  • Track 9-1: Rodent models
  • Track 9-2: Lesion-induced models
  • Track 9-3: Spontaneous models
  • Track 9-4: Genetics associated with translational models
  • Track 9-5: Translational Research in dementia
  • Track 9-6: Development of anti-dementia drugs
  • Track 9-7: Pathophysiological pathways
  • Track 9-8: Occupational Therapy

  • Track 10-1: Gene Therapies
  • Track 10-2: Reminiscence therapy
  • Track 10-3: Physical and cognitive activities
  • Track 10-4: Antipsychotic Therapy & medication
  • Track 10-5: Mechanism-based therapeutic approaches
  • Track 10-6: Music as a therapy
  • Track 10-7: Dance as a therapy

  • Track 11-1: Treatment trials
  • Track 11-2: Diagnostic studies
  • Track 11-3: Prevention trials
  • Track 11-4: Quality of life studies

  • Track 12-1: Vaccine targets

  • Track 13-1: Breakthrough in Dementia

  • Track 14-1: Psychiatric / Mental status Evaluation